Nuwellis, Inc. (NUWE)
NASDAQ: NUWE · Real-Time Price · USD
1.810
+0.070 (4.02%)
At close: Jan 2, 2026, 4:00 PM EST
1.860
+0.050 (2.76%)
After-hours: Jan 2, 2026, 7:21 PM EST
Nuwellis Market Cap
Nuwellis has a market cap or net worth of $3 million as of January 2, 2026. Its market cap has decreased by -30.61% in one year.
Market Cap
3.00M
Enterprise Value
291.43K
1-Year Change
-30.61%
Ranking
Category
Stock Price
$1.81
Market Cap Chart
Since December 6, 2019, Nuwellis's market cap has decreased from $3.25M to $3.00M, a decrease of -7.48%. That is a compound annual growth rate of -1.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 2.89M | -29.09% |
| Dec 31, 2024 | 4.07M | 114.71% |
| Dec 29, 2023 | 1.90M | -65.92% |
| Dec 30, 2022 | 5.56M | -53.25% |
| Dec 31, 2021 | 11.90M | -35.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 6, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |